News & Updates
Media Inquiries
If you’re a member of the media and looking to speak with an expert at Reproductive Equity Now, contact our press team at press@reproequitynow.org!
If you have a general question or comment, please email info@reproequitynow.org.
Governor Healey Signs Legislation Removing Massachusetts’ Arbitrary Abortion Ban
Today, Massachusetts Governor Maura Healey signed the Prioritizing Patient Access to Care Act into law, legislation that would expand abortion access throughout pregnancy in Massachusetts by removing the arbitrary restriction on abortion care after 24 weeks.
Reproductive Equity Now Statement on the Confirmation of Todd Blanche as Attorney General
Today, the Senate narrowly voted to confirm Donald Trump’s personal lawyer and nominee for U.S. Attorney General, Todd Blanche. His confirmation severely threatens abortion access and all reproductive health care nationwide.
Massachusetts Senate Passes Legislation Repealing Gestational Ban
Today, the Massachusetts Senate passed the Prioritizing Patient Access to Care Act, legislation sponsored by Senator Robyn Kennedy that would expand abortion access throughout pregnancy in Massachusetts by removing the arbitrary restriction on abortion care after 24 weeks. This legislation will soon head to Massachusetts Governor Maura Healey’s desk for signature.
Reproductive Equity Now Proudly Announces Slate of 2026 Connecticut Primary Legislative Endorsements
Today, Reproductive Equity Now proudly announced its full slate of endorsements in the Connecticut Senate and House of Representatives for the 2026 primary election cycle.
ICYMI: Maryland Doctor Details Caring for Massachusetts Patients Denied Abortion Care at Home
CommonWealth Beacon published an opinion piece by Dr. Diane Horvath, a Maryland-based obstetrician-gynecologist, highlighting how Massachusetts patients are routinely forced to travel out of state to her clinic in Maryland for abortion care because of the Commonwealth’s current law.
Massachusetts House Passes Legislation Repealing Gestational Ban
Today, the Massachusetts House of Representatives passed the Prioritizing Patient Access to Care Act (H. 5595), legislation that would expand abortion access throughout pregnancy in Massachusetts by removing the arbitrary restriction on abortion care after 24 weeks.
Repro Equity Now Celebrates Ayotte’s Veto of Bill to Restrict Abortion Care
After advocacy from Reproductive Equity Now and movement partners, Governor Kelly Ayotte today vetoed HB 232, a bill that would have further restricted abortion access in the Granite State.
Four Years Post-Dobbs: Because of Shield Law Protections, More Abortions Are Being Provided Than Ever Before
Reproductive Equity Now released a statement ahead of tomorrow’s fourth anniversary of the Dobbs v. Jackson Women’s Health decision.
Reproductive Equity Now Proudly Announces Slate of 2026 Massachusetts Primary Legislative Endorsements
Today, Reproductive Equity Now proudly announced its full slate of endorsements in the Massachusetts Senate and House of Representatives for the 2026 primary election cycle.
Civil Rights and Reproductive Justice Groups Applaud Unanimous House Passage of Massachusetts Consumer Data Privacy Act
The Massachusetts House of Representatives today voted unanimously to pass the Massachusetts Consumer Data Privacy Act. This major legislation would establish strong, enforceable protections against the abuse, misuse, and exploitation of extremely sensitive personal information collected every day by massive technology companies.
Reproductive Equity Now Proudly Announces First Massachusetts Endorsements of 2026
Today, Reproductive Equity Now proudly announced its first slate of endorsements in Massachusetts for the 2026 election cycle, endorsing:
Maura Healey for Governor
Kim Driscoll for Lieutenant Governor
Andrea Campbell for Attorney General
Reproductive Equity Now Celebrates Supreme Court Order to Allow Telehealth Access to Mifepristone to Continue
Today, after extending its temporary administrative stay of the U.S. Court of Appeals for the Fifth Circuit ruling in Louisiana v. FDA, the United States Supreme Court granted the request from Danco Laboratories and GenBioPro to restore access to mifepristone, the first drug used in a common two-drug medication abortion regimen, via the mail, while the court considers the manufacturers’ appeal.
Reproductive Equity Now Responds After Supreme Court Extends Temporary Stay, Allowing Telehealth Access to Mifepristone Until Thursday
Today, the United States Supreme Court extended the temporary administrative stay that restored access to mifepristone, the first drug used in a common two-drug medication abortion regimen, via the mail until at least Thursday, May 14, 2026.
Connecticut Leaders Call for Urgent Action to Protect Telehealth Abortion Access Amid Ongoing Court Chaos
Today, Connecticut leaders, including Connecticut’s Governor Ned Lamont and Attorney General William Tong, lawmakers, and advocates called for urgent state action to protect telehealth abortion access following rapidly shifting federal court rulings in Louisiana et al. v. Food and Drug Administration. Watch the full press conference HERE.
Reproductive Equity Now Statement After Supreme Court Temporarily Restores Telehealth Mifepristone Access
Today, the United States Supreme Court issued an ordertemporarily restoring access to mifepristone, the first drug used in a common two-drug medication abortion regimen, via the mail and retail pharmacy. The order, issued by Justice Samuel Alito, the justice who manages emergency requests regarding the Fifth Circuit, imposes a temporary pause on a U.S. Court of Appeals for the Fifth Circuit ruling from Friday night that reinstated medically unnecessary restrictions on mifepristone, until at least May 11. Justice Alito ordered Louisiana to respond by Thursday at 5 p.m. From there, the full U.S. Supreme Court will determine how to proceed.
Reproductive Equity Now Decries the Biggest Blow to Abortion Access Since the Dobbs Decision
Reproductive Equity Now released a statement following the U.S. Court of Appeals for the Fifth Circuit decision’s ruling in Louisiana et al. v. Food and Drug Administration(FDA), which reimposes medically unnecessary in-person dispensing requirements on mifepristone, the first drug used in the common two-drug regimen for medication abortion.
Reproductive Equity Now Applauds Reproductive Health Equity Investments in Massachusetts House State Budget
Yesterday, the Massachusetts House of Representatives advanced its annual budget for Fiscal Year 2027. Included in the budget are several priorities championed by Reproductive Equity Now as part of the organization’s efforts to urge the legislature to invest in reproductive health care access for Bay Staters.
Advocates Call on Lawmakers to Deliver on Reproductive Health Before Session Ends
With only one week left in the legislative session, reproductive rights advocates, medical professionals, and community leaders gathered today at the Connecticut General Assembly to press lawmakers to act now and pass critical reproductive health legislation.
New Hampshire Senate Judiciary Committee to Hold Hearing on Shielding Anti-Abortion Centers from Oversight
Reproductive Equity Now’s New Hampshire State Director, Christina Warriner Hamilton, released the following statement in advance of a public hearing in the Senate Judiciary Committee on Shielding So-Called “Pregnancy Resource Centers” from Future Oversight (HB 1416), legislation that would bind future legislatures from regulating facilities that often promote anti-abortion disinformation.